These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32583529)

  • 1. Effect of reoxygenation on hypofractionated radiotherapy of prostate cancer.
    Kuperman VY; Lubich LM
    Med Phys; 2020 Oct; 47(10):5383-5391. PubMed ID: 32583529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiobiological model of reoxygenation and fractionation effects.
    Guerrero M; Carlson DJ
    Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy.
    Cui M; Gao XS; Li X; Ma M; Qi X; Shibamoto Y
    Radiat Oncol; 2022 Mar; 17(1):54. PubMed ID: 35303922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
    Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
    Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
    Shibamoto Y; Miyakawa A; Otsuka S; Iwata H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i76-i82. PubMed ID: 27006380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.
    Fowler JF
    Acta Oncol; 2005; 44(3):265-76. PubMed ID: 16076699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What hypofractionated protocols should be tested for prostate cancer?
    Fowler JF; Ritter MA; Chappell RJ; Brenner DJ
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1093-104. PubMed ID: 12829147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypofractionated irradiation of prostate cancer: What is the radiobiological understanding in 2017?].
    Cosset JM
    Cancer Radiother; 2017 Oct; 21(6-7):447-453. PubMed ID: 28847464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
    Lindblom E; Dasu A; Toma-Dasu I
    Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
    Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
    Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Radiobiological Advantages of Hypofractionation Compared with Conventional Fractionation: Early-Passage NSCLC Cells are Less Aggressive after Hypofractionation.
    Zhang H; Wan C; Huang J; Yang C; Qin Y; Lu Y; Ma J; Wu B; Xu S; Wu G; Yang K
    Radiat Res; 2018 Dec; 190(6):584-595. PubMed ID: 30234458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.
    Miralbell R; Roberts SA; Zubizarreta E; Hendry JH
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e17-24. PubMed ID: 21324610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intratumor heterogeneity on BED for hypofractionated dose regimens.
    Kuperman VY
    Med Phys; 2019 Oct; 46(10):4690-4698. PubMed ID: 31257607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionation for clinically localized prostate cancer.
    Hickey BE; James ML; Daly T; Soh FY; Jeffery M
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is biochemical relapse-free survival after profoundly hypofractionated radiotherapy consistent with current radiobiological models?
    Tree AC; Khoo VS; van As NJ; Partridge M
    Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):216-29. PubMed ID: 24529742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative radiobiological analysis and preliminary results of Ultra hypofractionated accelerated radiotherapy for low-risk prostate cancer patients.
    Nanos C; Souftas V; Zisimopoulos A; Abatzoglou I; Koukourakis MI
    J BUON; 2021; 26(3):956-963. PubMed ID: 34268959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionation: what does it mean for prostate cancer treatment?
    Liao Y; Joiner M; Huang Y; Burmeister J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):260-8. PubMed ID: 19879698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).
    Wang JZ; Li XA; D'Souza WD; Stewart RD
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):543-52. PubMed ID: 12957268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.